The only FDA‑approved, evidence-based therapy for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.1

Read the FDA Approval Press ReleaseLearn More About Product Availability

Join Catalyst Pathways

A free, personalized program that offers patients and families one‐on‐one support through their treatment journey

Download Enrollment FormVisit Website

Get updates about FIRDAPSE

Sign up to stay informed with important news about FIRDAPSE.

NOTE: By providing this information you are only requesting more information about FIRDAPSE and are not signing up for Catalyst Pathways™.

All fields are required.